-
Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Beth Israel Deaconess Medical Center (BIDMC), Boston, Mass. Weill Cornell Medical College, New York, N.Y. Business: Diagnostic Quest launched a molecular blood test in …
Published on 3/26/2012
-
Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Cancer Roche launched Zelboraf vemurafenib in the U.K. to treat unresectable or metastatic melanoma in patients with BRAF V600 mutations. The European …
Published on 3/26/2012
-
Almirall S.A. (Madrid:ALM), Barcelona, Spain GW Pharmaceuticals plc (LSE:GWP), Salisbury, U.K. Business: Musculoskeletal Almirall and GW added Mexico to a 2005 deal granting Almirall exclusive marketing rights to …
Published on 3/19/2012
-
BioDelivery Sciences International Inc. (NASDAQ:BDSI), Raleigh, N.C. Business: Neurology BioDelivery said the U.S. relaunch of pain drug Onsolis fentanyl is being postponed so that two appearance issues raised by FDA …
Published on 3/19/2012
-
MorphoSys AG (Xetra:MOR), Martinsried, Germany Business: Diagnostic MorphoSys said a HuCAL antibody from its AbD Serotec division was included for use in an undisclosed supplier's diagnostic test related to maternal …
Published on 3/19/2012
-
Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Inflammation Takeda's Nycomed unit launched Omnaris ciclesonide nasal spray in the United Arab Emirates to treat allergic rhinitis in patients over the…
Published on 3/19/2012
-
20/20 GeneSystems Inc., Rockville, Md. Business: Diagnostic 20/20's Genesys BioLabs division launched PAULA's blood test for the early detection of lung cancer. The test scores patients' risk of lung cancer based on …
Published on 3/12/2012
-
Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Business: Pharmaceuticals Abbott's Starlims Corp. company acquired five of its distribution partners. The acquisitions included Varilab, two undisclosed private Spanish …
Published on 3/12/2012
-
Altogen Biosystems Inc., Las Vegas, Nev. Business: Supply/Service Altogen launched its Pancreas-targeted siRNA In Vivo RNAi Transfection Kit worldwide for use in laboratories and research facilities. The liposome-based …
Published on 3/12/2012
-
Boehringer Ingelheim GmbH, Ingelheim, Germany Eli Lilly and Co.(NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic Boehringer Ingelheim and partner Eli Lilly launched Jentadueto linagliptin/metformin in the U.S…
Published on 3/12/2012
-
Cornerstone Therapeutics Inc. (NASDAQ:CRTX), Cary, N.C. Merus Labs International Inc. (TSX:MLI; NASDAQ:MSLI), Toronto, Ontario Business: Infectious Merus acquired North American rights to Factive gemifloxacin mesylate …
Published on 3/12/2012
-
diaDexus Inc. (OTCBB:DDXS), South San Francisco, Calif. Business: Diagnostic diaDexus launched its PLAC Test in Europe to measure lipoprotein-associated phospholipase A2 (Lp-PLA2) as an aid to assess the risk for …
Published on 3/12/2012
-
Dr. Reddy's Laboratories Ltd. (NYSE:RDY), Hyderabad, India Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Neurology, Generics Dr. Reddy's launched a generic version of Pfizer's Geodon ziprasidone in the U.S. to treat …
Published on 3/12/2012
-
Horizon Pharma Inc. (NASDAQ:HZNP), Deerfield, Ill. Mundipharma International Ltd., Cambridge, U.K. Business: Autoimmune The companies added 17 territories to their 2010 deal granting Mundipharma exclusive rights to …
Published on 3/12/2012
-
Illumina Inc. (NASDAQ:ILMN), San Diego, Calif. Business: Genomics Illuminasaid its TruSeqAmplicon - Cancer Panel to detect somatic mutations is available for order and will begin shipping worldwide next month. The panel…
Published on 3/12/2012
-
KingMed Diagnostics, Guangzhou, China Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Business: Diagnostic Qiagen and KingMed will co-market Qiagen's Digene HPV test in China. Qiagen, which said partnering …
Published on 3/12/2012
-
Leo Pharma A/S, Ballerup, Denmark Business: Autoimmune Leo Pharma's Leo Pharma Inc. subsidiary said that last November it launched a patient assistant program for its Taclonex ointment and Taclonex Scalp topical …
Published on 3/12/2012
-
Mela Sciences Inc. (NASDAQ:MELA), Irvington, N.Y. Business: Diagnostic Mela Sciences launched MelaFind in the U.S. and Germany to aid in the detection of melanoma. MelaFind is a computer-controlled tool that identifies …
Published on 3/12/2012
-
Pfizer Inc. (NYSE:PFE), New York, N.Y. Ranbaxy Laboratories Ltd. (NSE:RANBAXY; BSE:500359), Gurgaon, India Business: Endocrine/Metabolic Ranbaxy launched a generic version of cholesterol therapy Lipitor atorvastatin in …
Published on 3/12/2012
-
Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Business: Diagnostic Qiagen's Ipsogen S.A. subsidiary launched its NPM1 MutaScreen worldwide to determine nucleophosmin (NPM1; B23) mutation status in …
Published on 3/12/2012
-
Simcere Pharmaceutical Group (NYSE:SCR), Nanjing, China Business: Autoimmune Simcere disclosed in its 4Q11 earnings that during 1Q12 it launched Iremod iguratimod to treat rheumatoid arthritis (RA) in China. China's …
Published on 3/12/2012
-
SystagenixWound Management Ltd., Crawley, U.K. Business: Dermatology In January, Systagenix launched WOUNDCHEK Protease Status in Europe, the Middle East and Africa to detect elevated protease activity (EPA) in chronic …
Published on 3/12/2012
-
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel Watson Pharmaceuticals Inc. (NYSE:WPI), Parsippany, N.J. Abbott Laboratories (NYSE:ABT), Abbott Park, Ill. Business: Genitourinary, Generics Teva …
Published on 3/12/2012
-
Sanofi(Euronext:SAN; NYSE:SNY), Paris, France Business: Endocrine/Metabolic Sanofi's Genzyme Corp. unit said it began shipping Fabry's disease therapyFabrazymeagalsidase beta manufactured at its newly approved …
Published on 3/5/2012
-
ViroPharma Inc. (NASDAQ:VPHM), Exton, Pa. Business: Cardiovascular ViroPharma launched Cinryze in the U.K. for the treatment and pre-procedure prevention of acute attacks of hereditary angioedema (HAE) in adolescents …
Published on 3/5/2012